Discover real-time Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

Get real-time updates on Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock quotes, trades, and more. Make informed investments with Nasdaq.

Jan 7, 2025 · Regeneron Pharmaceuticals will share its fourth quarter and full year 2024 financial results, indicating transparency and commitment to informing stakeholders about its performance.

Jan 13, 2025 · Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research.

Nov 13, 2024 · --Regeneron Pharmaceuticals, Inc. today announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of Hematology 2024 Annual Meeting ...

Jan 6, 2025 · Whales with a lot of money to spend have taken a noticeably bullish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 10 trades.

Jan 2, 2025 · Financial giants have made a conspicuous bearish move on Regeneron Pharmaceuticals. Our analysis of options history for Regeneron Pharmaceuticals (NASDAQ: REGN ) revealed 10 unusual trades.

Dec 17, 2024 · 25 analysts have shared their evaluations of Regeneron Pharmaceuticals (NASDAQ:REGN) during the recent three months, expressing a mix of bullish and bearish perspectives.

Jan 10, 2025 · During the last three months, 22 analysts shared their evaluations of Regeneron Pharmaceuticals (NASDAQ:REGN), revealing diverse outlooks from bullish to bearish.

Dec 19, 2024 · Regeneron reveals positive Phase 2 results for two Factor XI monoclonal antibodies, targeting thrombosis with favorable safety profiles.